Related by context. All words. (Click for frequent words.) 77 Colon polyps 75 breast uterine 75 pancreatic lung 75 pancreatic prostate 74 colorectal gastric 74 prostate pancreatic 73 skeletal metastases 73 ovarian lung 73 hereditary predisposition 73 lymphomas leukemias 73 breast pancreatic 72 Squamous cell 72 testicular tumors 72 cancerdefine 72 endometrial hyperplasia 72 hormonally sensitive 72 ovarian breast 71 endometrial cancers 71 hormone receptor negative 71 prostate colon 71 oesophageal adenocarcinoma 71 Leukemias 71 Basal Cell 71 nonalcoholic steatohepatitis 71 ductal breast cancer 71 breast ovary 71 deCODE BreastCancer 71 Genetic variants 71 Erythropoietic therapies may 71 uterine ovarian 70 cystic fibrosis chronic pancreatitis 70 kidney urologic 70 intestinal polyps 70 cirrhosis liver failure 70 leukemia multiple myeloma 70 ovarian endometrial 70 osteosarcomas 70 Metastases 70 prostate cancer CaP 70 ovarian cervical 70 thromboembolic disease 70 abnormal vaginal bleeding 70 lobular carcinoma 70 fibrocystic disease 70 thrombo embolic 70 leukemias lymphomas 70 lung pancreatic 70 lymph node enlargement 70 prostate bladder 70 adrenocortical cancer 70 bladder ovarian 70 gastric cardia 70 Soy isoflavones 70 pancreas esophagus 70 untreated celiac disease 70 testicular germ cell 70 leiomyomas 70 Basal cell 70 colorectal adenoma 69 hormone refractory prostate 69 bladder cancers 69 fibrocystic 69 esophagus colon 69 prostate testicular 69 gastric carcinoma 69 deCODE ProstateCancer TM 69 ovarian pancreatic 69 prostate ovarian 69 ovarian colon 69 precursor lesions 69 oral squamous cell 69 endometrial kidney 69 precancerous condition 69 testicular cancers 69 metastatic prostate 69 pancreatic endocrine 69 polyp recurrence 69 benign noncancerous 69 bladder prostate 69 beta carotene supplementation 69 Magnesium deficiency 69 Heavy menstrual bleeding 69 lupus scleroderma 68 cervical breast 68 fibroids endometriosis 68 Carcinoid tumors 68 adenomatous 68 overt hepatic encephalopathy HE 68 myopathies 68 Chronic pancreatitis 68 Hashimoto thyroiditis 68 nonmelanoma skin cancers 68 Ovarian cysts 68 gynecologic malignancy 68 adenomatous polyps 68 unresectable tumors 68 familial predisposition 68 endometriosis ovarian cysts 68 hepatocellular carcinoma liver 68 antiplatelet medications 68 NSAID induced GI 68 arterial calcification 68 Cholangiocarcinoma 68 lichen planus 68 Candida infection 68 Ischemic heart 68 prostate carcinomas 68 hypovitaminosis D 68 colorectal lung 68 Squamous 68 KRAS oncogene 68 metastatic colorectal 68 nonmelanoma 68 nodal metastasis 68 Malignant tumors 68 LHRH receptor positive 68 Endometrial cancer 68 SIADH 68 precancerous cervical 68 pancreatic ovarian 68 LRP5 68 Menopausal hormone therapy 68 neuroendocrine cancers 68 PCNSL 68 localized prostate 68 CYT# potent vascular disrupting 68 colorectal prostate 68 primary hyperparathyroidism 68 esophagus bladder 68 elevated triglyceride levels 67 invasive lobular 67 metachronous 67 Papillary 67 basal cell carcinoma squamous 67 ADPKD 67 TNF blocker therapy 67 dysplastic lesions caused 67 hamartomas 67 endometrial breast 67 inflammatory bowel syndrome 67 oligodendrogliomas 67 lobular cancer 67 dermatologic reactions 67 Autoimmune disorders 67 liver metastasis 67 alpha1 antitrypsin deficiency 67 pAkt 67 colorectal carcinoma 67 lobular carcinomas 67 antiphospholipid syndrome 67 familial pancreatic cancer 67 neoplasias 67 gastrointestinal stromal tumors GISTs 67 prostate carcinogenesis 67 MYH9 gene 67 cervical lymph node 67 gastric cancers 67 G6PD deficiency 67 inherited mutations 67 seminomas 67 urothelial cancer 67 transferrin saturation 67 HIV HCV coinfected 67 Squamous cell carcinomas 67 carotid plaques 67 ductal carcinomas 67 Li Fraumeni 67 invasive ductal breast cancer 67 hormonally responsive 67 squamous cell lung cancer 67 Adjuvant chemotherapy 67 surgically resectable 67 T1c 67 neurologic complications 67 premalignant lesion 67 radiosensitivity 67 bladder cervix 67 inhaled bronchodilators 67 gastric adenocarcinoma 67 obstructive coronary 67 lymphoma myeloma 67 leiomyoma 67 BRCA1 mutation carriers 67 cervical prostate 67 hypokalemia hypomagnesemia 67 smoldering myeloma 67 advanced adenoma 67 Thromboembolic 67 metastatic gastric 67 lobular breast cancer 67 pancreatic adenocarcinoma 67 colorectal adenocarcinoma 67 K ras mutations 67 colorectum 67 anticoagulants blood thinners 67 cisplatin resistant 67 ALI ARDS 67 colon ovarian 67 prostate abnormalities 67 Folic acid supplements 67 Heavy snorers 67 colon rectal 67 peritoneal carcinomatosis 67 HER2 positive breast 67 prostate carcinoma 66 Shark cartilage 66 impair fertility 66 Darapladib 66 cervical uterine 66 hypercalcaemia 66 ovarian hormones 66 Genetic predisposition 66 Zinc deficiency 66 neovasculature 66 urinary bladder cancer 66 transfusion syndrome 66 atrophic gastritis 66 Radical prostatectomy 66 Uterine cancer 66 hormonal abnormalities 66 multifactorial disease 66 polyps growths 66 lymph node removal 66 ovary uterus 66 atypical ductal hyperplasia 66 lymphoproliferative disorders 66 Viral infections 66 cranial irradiation 66 ABCB1 66 HER2 expression 66 receiving XGEVA 66 macrovascular events 66 advanced adenomas 66 gestational diabetes mellitus GDM 66 hematopoietic cancers 66 MTHFD1L gene 66 minimally symptomatic 66 basal cell skin 66 PLX STROKE targeting 66 colorectal pancreatic 66 leptin deficiency 66 cervical lymph nodes 66 Aortic stenosis 66 Non Alcoholic Fatty 66 BRCA1 BRCA2 66 leukemia lymphomas 66 nonhereditary 66 ischemic vascular 66 tumor metastases 66 hyperplasia BPH 66 uterus womb 66 trophoblastic 66 castration resistant hormone refractory 66 aerodigestive tract 66 diabetic kidney 66 Endometrial 66 ovarian uterine 66 allogeneic HSCT 66 BMPR2 66 esophageal gastric 66 metastatic bladder 66 Opportunistic infections 66 cause cardiac channelopathies 66 endocrine abnormalities 66 renal cell carcinomas 66 Hurthle cell 66 ductal cancer 66 pituitary tumors 66 Sezary syndrome 66 chronic periodontitis 66 nonischemic 66 progesterone receptor negative 66 cardiovascular disease hypertension 66 distal colon 66 spinal metastases 66 coagulation abnormalities 66 muscular dystrophy cystic fibrosis 66 Genetic mutation 66 urologic diseases 66 endocrine tumors 66 HER2 overexpression 66 valvular heart disease 66 leukaemias 66 Hormone pills 66 prolonged QT interval 66 Ischemic 66 Alessandro Riva 66 abnormal genital 66 colonic polyps 66 multiple sclerosis psoriasis 66 hyperinsulinism 66 malignant prostate 66 Vitamin B# deficiency 66 colon pancreas 66 chorioamnionitis 66 neuro developmental disorders 66 myeloperoxidase 66 haematopoietic 66 Calcium intake 66 gallstone disease 66 included exfoliative dermatitis 66 hypocalcaemia 66 antiproliferative effects 66 gastric pancreatic 66 CP CPPS 66 gallstone formation 66 recurrent metastatic 66 thyrotropin 66 nonalcoholic steatohepatitis NASH 66 thyrotoxicosis 66 polycystic ovarian syndrome PCOS 66 pulmonary metastasis 66 lung ovary 66 Cryptococcus neoformans 66 lumbar disk herniation 66 invasive carcinoma 66 node metastases 65 lung metastasis 65 colorectal neoplasms 65 mutated K ras 65 fibrocystic breast disease 65 pelvic malignancies 65 Benign breast 65 polycystic ovarian disease 65 Genetic variations 65 liver scarring 65 orchitis 65 B7 H3 65 epithelial tumors 65 Thyroid disorders 65 Chlamydia trachomatis infection 65 hyperhomocysteinemia 65 intravenous bisphosphonates 65 Folate deficiency 65 Ovary removal 65 cryptoxanthin 65 hypervascular tumors 65 Adenomas 65 atypical hyperplasia 65 Peritoneal mesothelioma 65 colon adenomas 65 Genetic mutations 65 Atherosclerotic 65 obese postmenopausal 65 male hormones androgens 65 p# mutations 65 BRCA2 gene mutation 65 Hematologic 65 myeloproliferative neoplasms 65 Androgen deprivation therapy 65 carotid atherosclerosis 65 Fatty liver 65 myopathy rhabdomyolysis 65 bowel cancers 65 thymectomy 65 situ LCIS 65 carcinoid tumor 65 subependymal giant cell 65 basal cell nevus syndrome 65 tryptase 65 Nonalcoholic Fatty Liver Disease 65 HBeAg negative 65 pulmonary metastases 65 dysplasias 65 systemic scleroderma 65 postmenopausal hormone replacement 65 colorectal bladder 65 cutaneous lupus 65 Lowering cholesterol 65 facial clefts 65 hypercoagulability 65 microangiopathy 65 finasteride Proscar 65 hematological disorders 65 Systemic lupus erythematosus 65 Lipoic acid 65 HNSCC 65 Kufs disease 65 pre cancerous growths 65 thyroid dysfunction 65 Nonalcoholic fatty liver 65 cervix vagina 65 chromosomal anomalies 65 metastatic lymph nodes 65 gastrointestinal cancers 65 histologic subtype 65 postoperative morbidity 65 pancreatic colon 65 pancreatitis inflammation 65 thyroid nodules 65 Estrogen receptor positive 65 nonbacterial prostatitis 65 Leydig cell 65 nephrolithiasis 65 Treatment Shows Promise 65 basal cell carcinoma BCC 65 prostate cancer metastases 65 proliferative disorders 65 carcinoid 65 Polycystic Ovary Syndrome 65 Barrett esophagus BE 65 endometrial carcinoma 65 fibroadenomas 65 lobular involution 65 PIK3CA 65 HER2 positive metastatic 65 urothelial carcinoma 65 cardiovascular disease osteoporosis 65 serous ovarian cancer 65 T1DM 65 Ribavirin causes 65 locoregional recurrence 65 HER2 positive cancers 65 throat esophagus 65 ANCA associated 65 endometrial ovarian 65 cervical carcinoma 65 macrovascular complications 65 Polycystic ovary syndrome PCOS 65 proximal colon 65 stratifying patients 65 aromatase inhibitors AIs 65 radiosensitive 65 metastatic bone 65 AAT deficiency 65 bile duct cancers 65 postoperative pulmonary 65 fibrate drugs 65 premalignant lesions 65 cardio metabolic diseases 65 AML MDS 65 histological subtype 65 lymphoid tumors 65 renal carcinoma 65 grade serous ovarian 65 CTAP# Capsules 65 bronchogenic carcinoma 65 relapsed ALL 65 Vitamin D insufficiency 65 bowel polyps 65 neovascular diseases 65 mental retardation epilepsy 65 chronic prostatitis 65 Thyroid nodules 65 genitourinary tract 65 symptom flare ups 65 constipation hemorrhoids 65 hormone therapy estrogen 65 cutaneous melanoma 65 corticosteroid induced 65 pheochromocytoma 64 oesophageal cancers 64 Sjögren syndrome 64 GISTs 64 Ovarian Cancers 64 bacterial prostatitis 64 dietary acrylamide 64 benign prostatic hypertrophy 64 squamous cell carcinoma SCC 64 colon breast 64 subclinical disease 64 Invasive Breast Cancer 64 bone marrow suppression 64 motor neuron degeneration 64 hemorrhagic complications 64 biliary cancer 64 thyroid carcinoma 64 mycosis fungoides 64 benign prostatic hyperplasia enlarged 64 prostate adenocarcinoma 64 autoimmune thyroid 64 pituitary adenomas 64 cervical ovarian 64 colon tumors 64 hormone receptor status 64 PCOD 64 acute porphyria 64 seminoma 64 kidney fibrosis 64 microvascular disease 64 Estrogens 64 breast abscesses 64 BRCA deficient 64 dysplastic lesions 64 hamartoma 64 epithelial cancers 64 tumor subtype 64 Abscesses 64 mucosal inflammation 64 abdominal adiposity 64 papillary renal cell carcinoma 64 tamoxifen Nolvadex ® 64 Vertebral compression fractures 64 GBA mutations 64 Contraceptive pill 64 DVT PE 64 bacteriuria 64 deep venous thromboses 64 deafness meningitis 64 alpha1 antitrypsin AAT deficiency 64 ductal adenocarcinoma 64 chlamydial infections 64 precancerous tumors 64 immunocompetent 64 FGFR2 gene 64 vaginal yeast infections 64 Enlarged prostate 64 Neurological disorders 64 metastatic neuroendocrine tumors 64 bilateral oophorectomy 64 CDH1 64 malignant brain 64 BRCA2 carriers 64 metastatic renal 64 multiple sclerosis inflammatory bowel 64 underlying pathophysiology 64 Postmenopausal hormone therapy 64 probiotic supplementation 64 breast carcinoma 64 basal cell cancers 64 neuroblastoma tumors 64 Squamous Cell 64 thyrotropin levels 64 diagnose coronary artery 64 Acute Renal Failure 64 mitochondrial toxicity 64 treating cancerous tumors 64 antiphospholipid antibodies 64 carotid artery blockage 64 cancerous enlargement 64 NSAID associated 64 Cysts 64 Fibroblast 64 post transplant lymphoproliferative 64 recurrent ovarian 64 Genetic variation 64 Chlamydia psittaci 64 nasopharyngeal carcinoma 64 uterine cancers 64 uterine tumors 64 nephropathy kidney 64 commercialize deforolimus 64 Chlamydia pneumoniae 64 PKCi 64 Precancerous 64 Selenium supplements 64 mutated BRAF gene 64 refractory Hodgkin 64 postoperative delirium 64 hepatocellular liver 64 DNA methylation patterns 64 congenital deficiency 64 carotid stenosis 64 chronic rheumatic 64 molecular abnormalities 64 Chronic lymphocytic leukemia 64 haematologic 64 noncancerous tumors 64 peritoneal cancer 64 membranous nephritis 64 circulating estrogens 64 malignant pancreatic 64 colorectal tumors 64 urogenital tract 64 hyperphenylalaninemia HPA due 64 myeloproliferative diseases 64 fronto temporal dementia 64 bony metastases 64 postoperative AF 64 obesity insulin resistance 64 cardiac malformations 64 immunotherapeutic approaches 64 inherited predisposition 64 CVD mortality 64 malignant neoplasm 64 gastric carcinogenesis 64 nonproliferative 64 Melasma 64 vascular disorders 64 echocardiographic parameters 64 birth defects miscarriages 64 Ischaemic heart 64 Clusterin 64 chronic thromboembolic pulmonary 64 Beta thalassemia 64 Oxidative damage 64 hyperparathyroidism 64 Statin therapy 64 colon prostate 64 Drug Prevents 64 immunodeficiency disorders 64 pre malignant lesions 64 p# biomarker 64 GSTT1 64 gastroesophageal 64 Alzheimer disease vascular dementia 64 incidentalomas 64 immune dysregulation 64 overexpress HER2 64 lung colorectal 64 potentially modifiable 64 Premature menopause 64 Thalomid ® 64 metastatic malignant 64 esophageal reflux 64 serum selenium 64 Androgens 64 colorectal adenomas 64 TTR amyloidosis 64 nonvascular 64 idiopathic pulmonary 64 reproductive abnormalities 64 elevated fasting glucose 64 Fibroid tumors 64 RET PTC rearrangements 64 chronic hepatitis cirrhosis 64 Celiac sprue 64 skeletal muscle weakness 64 de ath 64 embryonal rhabdomyosarcoma 64 breast cancer metastasis 64 Radiographic findings 64 glioblastoma tumor 64 diffuse gastric 64 pediatric malignancies 64 nonmetastatic 64 Bisphosphonate 64 spontaneously regress 64 radioiodine therapy 64 proliferative diabetic retinopathy 64 nonmelanoma skin cancer 64 IDH mutations 64 gestational hypertension 64 severe hypersensitivity reactions 64 Benign tumors 64 myelomas 64 psoriatic arthritis PsA 64 CMV infections 64 MCF7 64 Relapsing remitting MS 64 degenerative neurological diseases 64 idiopathic PAH 64 HER2 amplified 64 Wilms tumors 64 gastrointestinal GI bleeding 64 endogenous estrogen 64 tumor histology 64 CHD CVD 64 FGFs 64 Carcinomas 64 neurofibromas 64 monogenic 64 narcolepsy cataplexy 64 diarrhea colitis 64 heartburn GERD 64 Von Willebrand disease 64 Epstein Barr virus EBV 64 Inflammatory bowel diseases 64 hepatic toxicity 64 phyto oestrogens 64 premenstrual syndrome PMS 64 torsade de pointes 64 neoplastic 64 unmeasured factors 64 precancerous polyp 64 Acute Exacerbations 64 secondary hyperparathyroidism 64 neuritic 64 SIMPONI ® 64 autonomic dysfunction 64 plasminogen activators 64 chronic granulomatous disease 63 asymptomatic bacteriuria 63 Legg Calvé Perthes disease 63 neoplastic cells 63 colonoscopy sigmoidoscopy 63 Acute myeloid leukemia 63 pancreatic islet 63 IL 1Ra 63 diabetic microvascular complications 63 colorectal cancer CRC 63 Polycystic 63 enterocolitis 63 pancreas pancreatitis 63 Mitomycin C 63 erythema nodosum 63 neoplastic diseases 63 gene BRCA2 63 H. pylori eradication 63 ovarian malignancy 63 familial polyposis 63 oncogenic HPV 63 triacylglycerol concentrations 63 malabsorptive 63 carcinoid tumors 63 underactive thyroid gland 63 oncogenic transformation 63 esophageal cancers 63 esophagus pancreas 63 ADAMTS# 63 biliary tract disease 63 damage cirrhosis liver 63 removed laparoscopically 63 SOD2 gene 63 hepatic renal 63 Irritable Bowel 63 familial clustering 63 fibroma 63 Acoustic neuromas 63 ulcerative colitis Crohn disease 63 Uncontrolled hypertension 63 chronically immunosuppressed solid 63 ovarian colorectal 63 chronic obstructive airway 63 thrombotic complications 63 lung esophageal 63 leukemia myeloma 63 latent celiac disease 63 Prostatitis 63 Venous thromboembolism 63 SSc 63 Eisenmenger syndrome 63 platelet dysfunction 63 paraganglioma 63 cystic ovaries 63 Premature Aging 63 corticosteroid therapy 63 Chronic inflammation 63 syncope fainting 63 Severe Primary IGFD 63 obstructive coronary artery 63 mesangial 63 atherosclerosis narrowing 63 mammographic density 63 pleiotropic effects 63 autosomal dominant polycystic kidney 63 penile cancers 63 Adequate vitamin D 63 recurrent bladder 63 Chronic Prostatitis 63 gastrointestinal reflux 63 solar keratosis 63 cutaneous squamous cell carcinoma 63 lung cancer asbestosis 63 collagen vascular 63 intracranial atherosclerosis 63 vitreous floaters 63 hypermethylated 63 Urinary tract 63 lupus erythematosus 63 subclinical hyperthyroidism 63 progressive dyspnea 63 androgens male 63 gastro oesophageal reflux 63 dysglycemia 63 distal colon cancer 63 discoid lupus 63 Autoantibodies 63 mucinous 63 hyperinsulinemia 63 Her2 positive 63 spongiform encephalopathies 63 Helicobacter pylori infection 63 mammographic breast density 63 Elevated PSA 63 myomas 63 thyroid deficiency 63 urolithiasis 63 recurrent UTI 63 diabetes mellitus DM 63 elevated CRP 63 Pseudomonas aeruginosa infections 63 Adenocarcinoma 63 Gliomas 63 oral antidiabetic medication 63 noncancerous prostate 63 Thiazolidinediones 63 PGDH 63 pulmonary toxicity 63 faulty BRCA genes 63 hepatocellular 63 antiangiogenic therapy 63 rheumatoid arthritis lupus 63 pretransplant 63 Colorectal cancers 63 cholestasis 63 dyskeratosis congenita 63 Myocardial infarction 63 Hepatocellular Carcinoma HCC 63 multisystem disease 63 gastrointestinal mucositis 63 ovulatory cycles 63 metaplasia 63 estrogen deficiency 63 catheter angiography 63 hereditary pancreatitis 63 vascular abnormalities 63 hepatic liver 63 colorectal polyp 63 Nonspecific 63 Aggressive Prostate Cancer 63 hematological parameters 63 Iron deficiency anemia 63 mTOR inhibitors 63 acadesine 63 conjugated estrogen 63 metastatic GIST 63 kidney adrenal 63 metastatic pancreatic 63 pulmonary dysfunction 63 Hyperlipidemia 63 Polycythemia vera 63 lipohypertrophy 63 invasive ductal 63 NMIBC 63 atypical lobular hyperplasia 63 medically inoperable 63 Glucocorticoids 63 paragangliomas 63 arthritis osteoporosis 63 Brain metastases 63 metastatic adenocarcinoma 63 nonseminoma 63 tuberous sclerosis TS 63 Phytoestrogens 63 fructose intolerance 63 Pericarditis 63 severe hepatic dysfunction 63 chronic inflammations 63 pelvic irradiation 63 Prostaglandins 63 Unsaturated fats 63 Microalbuminuria 63 resistant hormone refractory 63 hematopoietic malignancies 63 hypercholesterolaemia 63 genital herpes infections 63 lipid abnormalities 63 neovascularisation 63 postoperative atrial fibrillation 63 Nasal polyps 63 Catheter Associated 63 Glioma 63 GSTP1 63 Pulmonary hypertension 63 paraneoplastic 63 Chemotherapy induced 63 antimetabolites 63 Postmenopausal 63 multiple sclerosis lupus 63 impaired insulin secretion 63 intracranial hemorrhage ICH 63 endocrine therapies 63 deCODE BreastCancer TM 63 Uterine fibroids 63 malignant lymphoma 63 vascular dysfunction 63 trophoblast cells 63 haemolytic uraemic syndrome 63 mesothelioma asbestosis 63 glaucoma ischemia 63 cryptogenic cirrhosis 63 contralateral breast 63 EBV infection 63 chlamydial infection 63 allergic rhinitis hay fever 63 hereditary breast 63 emphysema chronic bronchitis 63 atherosclerotic cardiovascular 63 medullary thyroid 63 genetic polymorphisms 63 oral thrush 63 lymphatic cancers 63 Oral contraceptive 63 colon rectal cancer 63 thromboembolic complications 63 Epstein Barr Virus 63 PTEN protein 63 amyloid plaque formation 63 chemopreventive agent 63 Anthracycline 63 choriocarcinoma 63 inducible nitric oxide synthase 63 Cooked tomatoes 63 benign uterine 63 undergoing radical prostatectomy 63 melanoma basal cell 63 carcinoma HCC 63 sickle cell cystic fibrosis 63 etiologic 63 glomerulosclerosis 63 gastrointestinal stromal 63 penile anal 63 Myocarditis 63 carcinoids originate 63 benign prostate 63 BRAF mutant 63 induced mucositis 63 Avandia Actos 63 hyperplastic polyps 63 unmeasured confounding 63 Growth Hormone Deficiency 63 intestinal ulcers 63 Vidaza ® 63 C1 INH deficiency 63 varicella infection 63 systemic autoimmune 63 treating sarcoma testicular 63 lupus multiple sclerosis 63 interleukin IL -# 63 Elevated CRP 63 thalassemia sickle cell 63 Malignant glioma 63 cholangiocarcinoma 63 dysmotility 63 idiopathic pulmonary arterial hypertension 63 Gene Linked 63 Metastatic breast cancer 63 eccrine 63 amyloid deposition 63 Renal impairment 63 colorectal ovarian 63 astrocytomas 63 KIF6 gene 63 HbF 63 spontaneous regression 63 Sjogren Syndrome 63 Fanconi syndrome 63 non resectable metastatic 63 potassium sparing diuretics 63 thrombocytosis 63 adjuvant radiation 63 ZOMETA 63 perioperative complications 63 cytomegalovirus CMV 63 triglyceride concentrations 63 Antitumor Activity 63 R Saizen R 63 ovarian prostate 63 MGUS 63 neurovascular diseases 63 abnormal clotting 63 thromboxane A2 63 Hyperparathyroidism 63 GnRH agonists 63 System IPSS 63 papillary carcinoma 62 autoimmune pancreatitis 62 glaucoma macular degeneration 62 inhibit metastasis 62 biochemical abnormalities 62 benign moles 62 Bullous 62 Thal Dex 62 chemopreventive agents 62 hematological diseases 62 malignant polyps 62 frequently benign tumor 62 CellCept mycophenolate mofetil 62 HER2 positivity 62 inhibit platelet function 62 breast colon 62 glial tumors 62 adenocarcinomas 62 myeloproliferative neoplasms MPNs 62 Factor Receptor 62 synovial cells 62 predisposing factor 62 carotid plaque 62 AstraZeneca Arimidex 62 Probiotic bacteria 62 extramedullary 62 detecting precancerous 62 apolipoprotein E4 62 renal scarring 62 opportunistic pathogens 62 anemia thrombocytopenia 62 salivary gland tumors 62 transthyretin amyloidosis 62 gastrointestinal dysfunction 62 inappropriate antidiuretic hormone SIADH 62 APOL1 62 bullous 62 invasive lobular carcinoma 62 candidemia 62 bronchoalveolar 62 lymphoid organs 62 cardiometabolic disorders 62 Chronic illnesses 62 Systemic lupus erythematosus SLE 62 breast ovarian 62 fibrocystic changes 62 cryptogenic 62 androgen deficiency 62 Hormonal imbalances 62 insulin resistance precursor 62 intra arterial chemotherapy 62 genetic syndromes 62 Immunotherapeutic